Search

Your search keyword '"Zienciuk-Krajka A"' showing total 136 results

Search Constraints

Start Over You searched for: Author "Zienciuk-Krajka A" Remove constraint Author: "Zienciuk-Krajka A"
136 results on '"Zienciuk-Krajka A"'

Search Results

1. Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator

3. Genetic testing for inherited cardiovascular diseases. A position statement of the Polish Cardiac Society endorsed by Polish Society of Human Genetics and Cardiovascular Patient Communities

4. Left Ventricle Segmental Longitudinal Strain and Regional Myocardial Work Index Could Help Determine Mitral Valve Prolapse Patients with Increased Risk of Ventricular Arrhythmias

5. Application of Novel Technologies in Cardiac Electrotherapy to Prevent Complications

6. The Phenotypic Spectrum of a Mutation Hotspot Responsible for the Short QT Syndrome

7. Genetic testing for inherited cardiovascular diseases. A position statement of the Polish Cardiac Society endorsed by the Polish Society of Human Genetics and Cardiovascular Patient Communities.

8. Comprehensive Echocardiography of Left Atrium and Left Ventricle Using Modern Techniques Helps in Better Revealing Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy

11. How likely is the sense‐B‐noise to affect patients with subcutaneous implantable cardioverter‐defibrillators and can we solve that problem in every case?

12. Comparison of Preoperative ECG Screening and Device-Based Vector Analysis in Patients Receiving a Subcutaneous Implantable Cardioverter-Defibrillator.

13. Subcutaneous implantable cardioverter-defibrillators for the prevention of sudden cardiac death: five‑year single-center experience

14. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1

15. Comparison of clinical and echocardiographic parameters in patients with hypertrophic cardiomyopathy under and over 60 years of age

16. Association between the geographic region and the risk of familial atrioventricular nodal reentrant tachycardia in the Polish population

17. The novel pathogenic variant in the LMNA gene in a four-generation family with sudden deaths and cardiomyopathy: Utility of molecular autopsy

18. Clinical characteristics of patients with arrhythmic mitral valve prolapse in a single tertiary center: prevalence of electrocardiographic and myocardial abnormalities

19. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1

22. The prevalence of familial form of atrioventricular nodal reentry tachycardia in south-eastern regions of Poland

23. Segmental longitudinal strain as the most accurate predictor of the patchy pattern late gadolinium enhancement in hypertrophic cardiomyopathy

24. P1463Regional variation in survival rates among primary prevention implantable cardioverter-defibrillator recipients in Eastern and Northern Europe POLKARD Polish ICD Registry perspective

25. P1464A question of gender equality. Sex-related differences in survival after primary prevention implantable cardioverter-defibrillator implantation for dilated cardiomyopathy An analysis from POLKARD

27. Safety of antiviral and anti-inflammatory drugs prolonging QT interval in patients with coronavirus disease 2019: an opinion of the Heart Rhythm Section of the Polish Cardiac Society

29. Implantable cardioverter-defibrillators in patients with long QT syndrome: a multicentre study

30. Clinical characteristics of patients with arrhythmic mitral valve prolapse in a single tertiary center: prevalence of electrocardiographic and myocardial abnormalities

35. P1463Regional variation in survival rates among primary prevention implantable cardioverter-defibrillator recipients in Eastern and Northern Europe POLKARD Polish ICD Registry perspective

36. P1464A question of gender equality. Sex-related differences in survival after primary prevention implantable cardioverter-defibrillator implantation for dilated cardiomyopathy An analysis from POLKARD

39. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1

41. Left ventricular noncompaction cardiomyopathy: diagnostic and therapeutic dilemmas

42. Predictors of arrhythmia other than QT interval prolongation and the use of β-blocker therapy in the coronavirus disease 2019 pandemic. Authors' reply

43. Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1

44. Bilateral cardiac sympathetic denervation in catecholaminergic polymorphic ventricular tachycardia

47. Edoxaban versus warfarin in patients with atrial fibrillation

48. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

49. Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database

Catalog

Books, media, physical & digital resources